2011
DOI: 10.1007/s00213-011-2389-y
|View full text |Cite
|
Sign up to set email alerts
|

The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia

Abstract: Estrogen is functionally protective against 5-HT(1A)-, dopamine D(2)-, and NMDA receptor-induced PPI disruptions, while testosterone treatment enhances NMDA receptor-mediated PPI disruptions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
38
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 56 publications
(42 citation statements)
references
References 52 publications
(61 reference statements)
4
38
0
Order By: Relevance
“…Whatever precise mechanisms involved, our findings clearly add to the growing literature suggesting that estrogen--related substances may have therapeutic value in the treatment of psychosis--related behavioral and cognitive deficits (Arad and Weiner, 2010b;Frye et al 2007;Gogos et al 2006Gogos et al , 2010Gogos et al , 2012Uban et al 2012;Van den Buuse and Eikelis, 2001). For instance the ER--α agonist PPT seems to represent a remarkably potent pharmacological compound that could possibly modulate PPI in populations of patients with sensorimotor gating pathologies of distinct etiology/pathophysiology given its significant effects on PPI both in normo--dopaminergic and hyper--dopaminergic states.…”
Section: Discussionsupporting
confidence: 56%
See 3 more Smart Citations
“…Whatever precise mechanisms involved, our findings clearly add to the growing literature suggesting that estrogen--related substances may have therapeutic value in the treatment of psychosis--related behavioral and cognitive deficits (Arad and Weiner, 2010b;Frye et al 2007;Gogos et al 2006Gogos et al , 2010Gogos et al , 2012Uban et al 2012;Van den Buuse and Eikelis, 2001). For instance the ER--α agonist PPT seems to represent a remarkably potent pharmacological compound that could possibly modulate PPI in populations of patients with sensorimotor gating pathologies of distinct etiology/pathophysiology given its significant effects on PPI both in normo--dopaminergic and hyper--dopaminergic states.…”
Section: Discussionsupporting
confidence: 56%
“…These findings readily emphasize a putative role of dopamine--dependent mechanisms in the behavioral actions of ER--α and ER--β selective agonists. In support of this notion, E2 is known to affect dopaminergic neurocircuits (Sánchez et al 2010), and it has been proposed that such effects readily contribute to the modulatory effects of E2 on sensorimotor gating in the form of PPI (Gogos et al , 2012. Moreover, ER--α and ER--β are both expressed in some of the most important brain areas involved in the PPI circuitry, including the (ventral) striatum and midbrain dopaminergic nuclei (Kuppers and Beyer, 1999;Laflamme et al 1998;Shughrue et al 1997;Toran--Allerand, 2004).…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Additionally, some 'neuro-protective' effects of estrogen on DA and 5-HT NT system-related behaviours have been found, with estrogen exhibiting an ability to inhibit the DA D 2 and 5-HT 1A receptorinduced mediated behavioural changes in sensorimotor gating/information processing, which are deficient in people with mental illnesses (Dunlop and Nemeroff 2007;Gogos et al 2012). …”
Section: Discussionmentioning
confidence: 99%